V6 is developing an accommodating intraocular lens for placement in patients’ eyes post-cataract surgery.

biopharmaceuticals
Private
NA
Additional Portfolio Companies
ABAC Therapeutics
Adicet Bio
ArQule
Cathworks
Dynacure
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Hairstetics
Horama
Keros Therapeutics
Kite Pharma
Levation Pharma
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Ocon Medical
Prevail Therapeutics
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave

Protalix (NYSE: PLX) is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx plant cell-based protein expression system. Using ProCellEx, Protalix isdeveloping a proprietary pipeline of biobetter and biosimilar recombinant proteins that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.

biopharmaceuticals
Public (NYSE:PLX)
Visit Website

NA

Additional Portfolio Companies
ABAC Therapeutics
Adicet Bio
ArQule
Cathworks
Dynacure
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Hairstetics
Horama
Keros Therapeutics
Kite Pharma
Levation Pharma
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Ocon Medical
Prevail Therapeutics
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave
December 7, 2017